Archived articles

Covid-19 vaccine

Virtual assistant
Chatbots battle COVID-19 vaccine hesitancy
Published March 24, 2022
Researchers at Johns Hopkins had already been developing chatbots to combat vaccine misinformation when the coronavirus pandemic arrived, giving their work greater urgency
Study: Children's antibody responses to COVID-19 are stronger than adults'
Published March 22, 2022
Findings differ from earlier reports of low antibody responses in children exposed to COVID-19 virus and suggest that even the youngest children may respond to vaccines if correct dose is determined
Key COVID-19 metrics decline, but experts say it's far from over
Published Feb 28, 2022
COVID-19 is inching toward endemic status in the U.S., but a clear seasonal pattern has yet to emerge. Meanwhile less than 66% of the total population has been vaccinated.
COVID-19 vaccine maintains strong protection against severe disease at six months
Published Feb 22, 2022
A pre-omicron study reviewed four vaccines, finding that they retain nearly all of their ability to prevent severe disease up to six months after full vaccination
Training ambassadors to talk to vaccine-hesitant parents
Published Feb 17, 2022
Rupali Limaye of the Bloomberg School of Public Health discusses the creation of a free virtual course for parents, teachers, and school staff to help them encourage other caregivers to make evidence-based decisions about vaccinating their children
Yes, you should get a booster
Published Jan 11, 2022
From preventing COVID-19 altogether to lessening symptoms and transmission with breakthrough infections, there are several good reasons to get an mRNA booster ASAP
Making sense of the messiness of omicron
Published Jan 10, 2022
In this Q+A, experts from the Johns Hopkins Bloomberg School of Public Health address some common questions and scenarios with what is known right now
Without global vaccinations, further variants ahead
Published Dec 21, 2021
Vaccine experts Anna Durbin and William Moss explain how vaccination prevents viral mutation, discuss remaining barriers to global vaccine access
COVID-19 continues to hound U.S. with new surge, new variant
Published Dec 21, 2021
As the pandemic's second year ends, the nation struggles to avoid a repeat of widespread lockdowns. But vaccinations continue to tame the impact—for now.
COVID-19 briefing
Omicron variant is likely everywhere, delta cases increasing
Published Dec 6, 2021
Delta remains dominant around the world while omicron emerges, though time will tell whether the new variant will challenge vaccine effectiveness